In addition, previous studies have demonstrated that KDM5A and KDM5C are overexpressed in gemcitabine-resistant pancreatic cancer cells and that their expression is regulated by CD44, a stem cell marker linked to chemoresistance. Here, CD44 is linked to familial pancreatic carcinoma.